Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

Biotechnology

Healthcare
$8.44 +3.04%

+$0.26 today

Market cap
$547.12M
Beta
1.80
P/E (TTM)
-1.7
EPS (TTM)
-$5.11
52W Low $5.37High $17.58

Volume 2.36M

Average 1.24M

Returns on capital

Ginkgo Bioworks Holdings, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-61.5%

avg -73.4%

ROIC

-30.0%

avg -49.9%

ROA

-27.9%

avg -46.9%

Analysis

ROA is currently the strongest return metric at -27.9% versus its period average of -46.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Steven Coen

Chief Financial OfficerUSD 438.69K60——

Reshma Shetty

Co-Founder, President & DirectorUSD 255K45——

Jason Kelly

Co-Founder, Co-COO, CEO & DirectorUSD 255K45——

Brian O'sullivan

Head of Commercial————

Daniel Marshall

Senior Manager of Communications & Ownership————

Jennifer Wipf

Co-Chief Operating Officer————

Karen Tepichin

General Counsel & Secretary————

Bartholomew Canton

Co-Founder & CTO————

Austin Che

Co-Founder & Head of Strategy————

Thomas Knight Jr.

Founder————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

0

$0.00

Sells

24

$4.95M

Net Transaction Value

−$4.95M

Net selling

Most Active

Coen Steven P.

10 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Oct 19, 26

Canton Barry

Indirect

Sell$226.9K
Oct 19, 26

Shetty Reshma P.

Indirect

Sell$190.7K
Oct 19, 26

Canton Barry

Direct

Sell$190.7K
Oct 19, 26

Shetty Reshma P.

Direct

Sell$226.9K
Oct 19, 26

Kelly Jason R

Direct

Sell$463.4K
Oct 19, 26

Coen Steven P.

Direct

Sell$7.8K
Oct 5, 26

Coen Steven P.

Direct

Sell$36K
Sep 15, 26

HENRY CHRISTIAN O

Direct

Sell$35.4K
Aug 24, 26

Coen Steven P.

Direct

Sell$2.3K
Jul 17, 26

Coen Steven P.

Direct

Sell$5.9K

1–10 of 24

Summary

Insiders reported 0 buys worth $0.00 and 24 sells worth $4.95M over the last 12 months. That adds up to net selling of $4.95M. Coen Steven P. was the most active insider with 10 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A-29.1%
+21.4% (4yr)1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Recent growth has been strongest in Revenue at -29.1% over three years. Forward estimates point to Revenue at +21.4% (4yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Ginkgo Bioworks Holdings, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about DNA's management, answered from reported figures.

Who manages DNA?

Ginkgo Bioworks Holdings, Inc. (DNA) lists 10 active executives. The top listed executive is Reshma Shetty, Co-Founder, President & Director.

Are DNA insiders buying or selling?

Recent insider activity shows net selling of $3.74M.